CXCL5 and neoplasm: Tumour-specific methylation of CXCL5 has also been observed in 80% of primary lung adenocarcinomas and 65% of lung adenocarcinoma cell lines [48], and demethylation using 5-Aza-2′-deoxycytidine also restored the expression of CXCL5[48].